Mauch C, Zamek J, Abety AN, Grimberg G, Fox JW, Zigrino P:
Accelerated wound repair in ADAM-9 knockout animals.
J Invest Dermatol 2010;130: 2120-2130

Teutschbein J, Haydn JM, Samans B, Krause M, Eilers M, Schartl M, Meierjohann S:
Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins.
BMC Cancer 2010; 10: 386

Schmidt J, Friebel K, Schönherr R, Coppolino MG, Bosserhoff AK:
Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium channels.
Cell Res 2010; 20: 1224-1238

Sinnberg T, Menzel M, Kaesler S, Biedermann T, Sauer B, Nahnsen S, Schwarz M, Garbe C, Schittek B:
Suppression of casein kinase 1α in melanoma cells induces a switch in β-catenin signaling to promote metastasis.
Cancer Res 2010; 70: 6999-7009

Landsberg J, Gaffal E, Cron M, Kohlmeyer J, Renn M, Tüting T:
Autochthonous primary and metastatic melanomas in Hgf-Cdk4 R24C mice evade T-cell-mediated immune surveillance.
Pigment Cell Melanoma Res 2010; 23: 649-660

Schartl M, Wilde B, Laisney JA, Taniguchi Y, Takeda S, Meierjohann S:
A mutated EGFR is sufficient to induce malignant melanoma with genetic background-dependent histopathologies.
J Invest Dermatol 2010; 130: 249-258

Schultz J, Koczan D, Schmitz U, Ibrahim SM, Pilch D, Landsberg J, Kunz M:
Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth.
Clin Exp Metastasis 2010; 27: 133-140

Eberle J, Spangler B, Becker JC, Heinemann SH, Klein CA, Kunz M, Kuphal S, Langer P, Mauch C, Meierjohann S, Paschen A, Schadendorf D, Schartl M, Schittek B, Schönherr R, Tüting T, Zigrino P, Bosserhoff AK; on behalf of German Melanoma Research Network of the German Cancer Aid:
Multicentre study on standardisation of melanoma cell culture - an initiative of the German Melanoma Research Network.
Pigment Cell Melanoma Res 2010; 23: 296-298

Kunz M, Driller KM, Hein M, Libnow S, Hohensee I, Ramer R, Hinz B, Berger A, Eberle J, Langer P:
Synthesis of Thia-Analogous Indirubin N-Glycosides and their Influence on Melanoma Cell Growth and Apoptosis.
ChemMedChem 2010; 5: 534-539

Presentations at the Joint Meeting of DGZ / Melanoma Research Network (10.-13.3.2010)

Kuphal S, Massoumi R, Haas B, Wild P, Pfeifer A, Bosserhoff A: Persistent NFkappaB activation in malignant melanoma is generated through loss of the tumor suppressor CYLD.

Spangler B, Kuphal S, Bosserhoff A: The cytoskeleton seems to be involved in the E-cadherin dependent regulation of c-Jun in malignant melanoma.

Haydn J, Schartl M, Meierjohann S: MEK inhibition protects melanoma cell lines from cisplatin induced apoptosis.

Schmitt A, Schartl M, Meierjohann S: Examination of peroxiredoxin 6 in human melanoma and the Xmrk melanoma fish model.

Schiffner S, Bosserhoff A: Melanoma inhibitory activity (MIA) acts as a mediator of oncogene-induced senescence in human melanocytes.

Mueller DW, Bosserhoff A: miRNA miR-196a controls several melanoma-relevant genes by regulating HOX-C8 expression.

Braig S, Müller DW, Rothhammer T, Bosserhoff A: MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma.

Schmidt J, Friebel K, Schönherr R, Coppolino MG, Bosserhoff A: Directed, migration-associated secretion of MIA at the cell rear regulates melanoma cell mobility.

Helfrich I, Scheffrahn I, Bartling S, Weis J, Middleton M, Kato M, Ergün S, Schadendorf D: The vascular phenotype, vessel stabilization and maturation affect the resistance to anti-angiogenic therapy in malignant melanoma.

Vokhminova D, Steinle A, Schadendorf D, Paschen A: Proteasome inhibition induces expression of the cell stress molecule MICB via HSF1.

Beck D, Niessner H, Sinnberg T, Kulms D, Vasseur S, Garbe C, Meier F: Dual targeting of RAF and mTOR potently induces apoptosis in melanoma cells through the endoplasmic reticulum stress pathway.

Sinnberg TW, Sauer B, Schittek B: Deciphering the role of the Y-box binding factor 1 in malignant melanoma.

Schönefuß A, Seyfarth B, Mauch C, Zigrino P, Tumor Biology Group: Molecular regulation of ADAM-9 expression in melanoma cells.

Abety N.A, Zamek J, Mauch C, Zigrino P: Stromal-derived ADAM-9 modulates growth of malignant melanoma in vivo and in vitro.

Haug D, Haydn J, Spangler B, Bosserhoff A, Schartel M, Meierjohann S: Impact of the AP-1 complex component FOSL1 on melanoma development.

Buttstädt N, Friebel K, Quast A, Eberle J, Heinemann SH, Schönherr R: TRAM-34, a selective inhibitor of the calcium-activated potassium channel IKCa1 has multiple effects on melanoma cells.

Berger A, Quast SA, Kunz M, Langer P, Eberle J: Sensitization of melanoma cells for TRAIL-induced apoptosis by MAPK inhibitors and indirubins correlates with decreased mitochondrial membrane potential.

Schmid R, Grässel S, Opolka A, Schubert T, Bosserhoff A: Enhanced cartilage repair in MIA/CD-RAP knockout mice.



"Melanomverbund meets ADO" vom 11.-13.9.2014

Beim 24. Deutschen Hautkrebskongress (11.-13. September 2014, Kap Europa Frankfurt) ist auch der...

Deutscher Krebspreis 2014

Prof. Christoph Klein, Projektleiter im Melanomverbund, mit dem Deutschen Krebspreis 2014...

2. International Symposium "Trends in Melanoma Research", 11.-13.12.2014, in Regensburg

The Melanoma Research Network "Molecular Mechanisms of Development and Progression of...

Symposium "Trends in Melanoma Research" 2013

We cordially thank you for your participation in our Symposium “Trends in Melanoma research” (June...